
    
      Stem cells therapy may be a choice therapy for advanced heart failure patients refractory to
      medical therapy, and a previous history of coronary artery diseases. In this study the
      investigators have evaluated consecutive 15 selected patients, the amelioration in failing
      heart NYHA class, hospitalization rate, echocardiographic left ventricle functionality, serum
      of Natriuretic peptide level and associated to reduction of angina after a treatment with
      stroma vascular fraction infusion y/or Stemregen capsule per oral.
    
  